The globalgout therapeutics marketsize is expected to reach USD 6,304.8 million by 2026 according to a new study by Polaris Market Research. The report“Gout Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Non-steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Colchicine, Urate Lowering Agents) Disease Condition (Acute, Chronic); By Regions, Segments & Forecast, 2020 – 2026”gives a detailed insight into current market dynamics and provides analysis on future market growth.
痛风的发病率和患病率增加over two-fold in past 20 years. This growth combined with increasing occurrence of comorbid conditions and cardiovascular risk factors represents a significant public health challenge. Globally, the developed countries tend to have a higher burden of gout compared to the developing countries, and also have increasing prevalence of this disease. There are various factors including genetic history, and ethnicity that could lead to occurrence of gout. Also, socioeconomic and dietary factors, as well as comorbidities and medications that can influence uric acid levels and facilitate MSU crystal formation, are also important in determining the risk of developing clinically evident gout.
Increasing geriatric population, and growing prevalence of this condition associated with this growing elderly population are the primary factors driving the growth of the industry. According to a study published in the Modern Medicine, elder population are more prone to develop tophi and the prevalence of metabolic syndrome among the elder population with gout was 62%. Currently, the geriatric population is growing at an extraordinary rate. According to the data published by the United Nations in 2012, global geriatric population was nearly 809.4 million in 2011 and is anticipated to grow more than double and reach over 2,000 million by 2050.
此外，在全球范围内越来越泛滥，增加研发活动，越来越多的产品批准，以及增加公共和私人投资的其他因素是在预测期内推动市场增长的因素。最近，在新西兰，HRC在奥塔哥大学提供了丽莎邮票教授，以引领首次随机对照试验，使用Allopurinol帮助更多患者管理他们的痛风症状。此外，2019年华盛顿州立大学的研究人员在2019年研究人员，健康科学斯波坎和其他地方确定了一种治疗痛风的新治疗目标。这种日益增长的研究研究正在推动预测期间市场的增长。
有问题吗？在通过单击下面的链接，请在购买此报告之前请求示例或进行查询：https://www.polarismarketreesearch.com/Industry-analysiss/gout-therapeutics-market/Request-for-sample.
However, factors such as patent expiry of blockbuster products, increasing competition in the generic sector and high cost of the newly launched drugs are likely to hinder the growth of this market during the forecast period. The cost associated with gout therapies is poised to increase dramatically due to federal policy decisions and pipeline developments. Also, patent expiry of major blockbuster agents and expected launch of generic version are likely to restrain the growth of the market during the forecast period. Entry of generic after its patent expiry would decline the revenue in future. Hence, high cost of the products and patent expiry of the medicines is a key factor to restrain the growth of the market.
全球市场由北美主导，因为美国和加拿大等国家有大量的患者基础，并且在该地区正在进行大量的研究活动。许多在该市场部分运营的公司都以美国为基础，因此新产品主要在该区域部分引入。痛风影响美国约830万人，流行范围为1-4％。与白种人相比，非洲裔美国人的痛风普遍存在较高，并预计将在几年内越来越多地增加所有人口统计。此外，政府还采取了各种措施，以引起意识，并为该地区痛苦的患者提供更好的医疗保健设施。乐动娱乐官网
此外，欧洲在全球产业中也有很大的份额。各种国际公司在欧洲市场推出了新产品。例如，2018年8月，Grünenthal获得了Duzallo（Lesinurad / Allopurinol）的欧洲批准，并扩大了其痛风组合。但是，亚太地区预计将在预测期内见证最快的增长。由于印度，中国，韩国和其他南亚国家等几个高经济增长的国家，这一最高增长主要预期。越来越多的人与吸烟和酒精消费相关，人口不断增长，越来越需要有效疗法，而且在这一区域部门中的当地和国际参与者的扩张也在促进了该地区痛风治疗性市场的增长。
该行业的主要参与者包括Astazeneca，Horizo n Pharma Plc，Takeda Pharmaceutical Limited，Glaxosmithkline Plc，Novartis AG，Merck＆Co.Inc，Teijin Pharma Limited，Regeneron Pharmaceuticals，Inc，Ironwood Pharmaceuticals，Inc。，JW Pharmaceutical，SelectaBiosciences，Inc。和Grunenthal Group等。
Polaris Market research has segmented the Gout Therapeutics market report on the basis of level, application, material type, product type, product style and region
Gout Therapeutics Drug Class Outlook (Revenue, USD Million, 2015 – 2026)
- 非甾体类抗炎药（NSAID）
- 皮质类固醇
- Colchicine
- 调整降低剂
Gout Therapeutics Disease Condition Outlook (Revenue, USD Million, 2015 – 2026)
- Acute
- Chronic
Gout Therapeutics Regional Outlook (Revenue, USD Million, 2015 – 2026)
- 北美
- 我们。
- Canada
- Europe
- Germany
- 英国
- France
- Italy
- Spain
- 比利时
- Rest of Europe
- 亚太地区
- 中国
- India
- Japan
- South Korea
- 澳大利亚
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of LATAM
- 中东和非洲
- 南非
- Saudi Arabia
- 剩下的MEA